Stock search

Ticker or company name

Cencora

COR · NYSE · Health Care

$356,94Down −2,09 (−0,58%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$68,5 bn
Div. yield
1,0%
Year to date
+3,4%
52 weeks: $244,82$377,54

Ratio score

83/100
Ratio would consider buying

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

6 ✓ · 3 — · 0 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM19,725,125,1
Forward P/E16,8—16,2
PEG2,4—2,2
P/S0,20,22,2
EV/EBITDA15,114,917,3
P/FCF10,9—19,5
P/B18,637,33,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 20 analysts

Buy
14
Hold
6
Sell
0

Beat the EPS forecast in 3 of the last 4 quarters

QuarterEstimateActualSurprise
Q4 20264,634,66Up +0,7%
Q3 20264,394,48Up +2,0%
Q2 20264,864,75Down −2,3%
Q1 20264,084,08Up 0,0%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23
Revenue84,8 bn78,4 bn85,9 bn83,7 bn80,7 bn75,5 bn81,5 bn79,1 bn74,2 bn68,4 bn72,3 bn68,9 bn
EPS3,948,402,87−1,743,523,682,500,042,422,092,981,73
Margin0,9%2,1%0,7%−0,4%0,9%1,0%0,6%0,0%0,7%0,6%0,8%0,5%
FCF2,43 bn1,17 bn−2,42 bn2,88 bn−74,0 m3,22 bn−2,82 bn818 m2,36 bn−991 m811 m1,65 bn

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: purchases $2,31 m (2 people), sales $15,4 m.

NameAmountSharesPrice
krikorian lazarus2 Nov 2026 · sale$326 327986$330,96
krikorian lazarus1 Oct 2026 · sale$298 935986$303,18
greenberg lon r16 Sep 2026 · sale$411 2641 280$321,30
krikorian lazarus1 Sep 2026 · sale$321 080985$325,97
campbell elizabeth s24 Aug 2026 · sale$3,66 m11 300$324,12
tyler lauren m22 Jun 2026 · open-market purchase$148 627550$270,23
durcan dermot mark18 Jun 2026 · open-market purchase$1,10 m4 000$274,19
durcan dermot mark28 May 2026 · open-market purchase$1,07 m4 000$266,26
mauch robert p.20 Feb 2026 · sale$1,35 m3 762$358,94
mauch robert p.18 Feb 2026 · sale$479 1601 333$359,46
mauch robert p.20 Jan 2026 · sale$1,81 m5 096$354,73
campbell elizabeth s19 Dec 2025 · sale$1,15 m3 351$342,10
battaglia silvana19 Dec 2025 · sale$578 5651 677$345,00
mauch robert p.18 Dec 2025 · sale$1,75 m5 096$343,45
krikorian lazarus17 Dec 2025 · sale$1,38 m4 031$343,24

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
US
IPO date
28 May 1996

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
CAHCardinal Health$283,85no score35,7——
BSXBoston Scientific$43,6983would consider18,4+8,9%16,6%
EWEdwards Lifesciences$107,1156would watch60,3+13,4%15,2%
CICigna$300,1689would consider13,1+6,8%2,3%
BDXBecton Dickinson$216,4738would not consider51,8−2,6%4,5%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.